Passacantilli, Ilaria <br/><br/>
Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition.  [electronic resource] 

 -  Oncotarget  Jul 2014 
 - 5381-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.2111  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Everolimus<br/>Humans<br/>Imidazoles--administration & dosage<br/>Neuroendocrine Tumors--drug therapy<br/>Pancreatic Neoplasms--metabolism<br/>Phosphorylation<br/>Quinolines--administration & dosage<br/>Signal Transduction<br/>Sirolimus--administration & dosage<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors